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Clostridium difficile infection (CDI) is one of the most widely 
known nosocomial infections. The dysbiosis of gut microbiota due to 
antibiotic use is the leading cause of CDI; people with relatively healthy 
gut microbiota do not typically become infected with CDI. It is, therefore, 
necessary for researchers to find a specific bacterium that inhibits CDI 
among healthy gut microbiota to regulate it. However, there have been few 
studies about CDI-resistant strains among healthy gut microbiota. 
Therefore, this study aims to verify the inhibitory effect of single strains 
isolated from normal individuals on CDI and to determine the underlying 
mechanism. Through previous studies, three strains isolated from healthy 
Koreans with C. difficile inhibitory effects were selected. The CDI 
inhibitory effects of the three strains were confirmed through animal 
experimentation. CDI inhibition was assessed by post-infection weight 
change, C. difficile colony forming unit (c.f.u.), and the toxin A&B 
measured value. The feces collected in the animal experiment were used to 
analyze the changes and status of gut microbiota and gut metabolome. As 
a result of this experiment, a significant inhibition of CDI was observed in 
the group to which Lactobacillus plantarum SNUG 10271 was 
administered. Gut microbiota analysis showed that Ruminococcaceae and 
Coprococcus showed high abundance in the L. plantarum SNUG 10271 
group and was negatively correlated with C. difficile. Gut metabolome 
analysis showed that the concentration of deoxycholic acid (DCA) was 
significantly higher in individuals with inhibitory effects. These results 
confirmed the possibility of CDI inhibition of a single strain isolated from 
healthy individuals. We also found information on Ruminococcaceae, 
Coprococcus, and DCA that will be necessary to understand the 
mechanism of CDI inhibition. 
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Clostridium difficile infection (CDI) is a bacterial infection 
caused by the Gram-positive, spore-forming bacterium Clostridium 
difficile [1]. Clostridium difficile infects the gastrointestinal tract, 
leading to colonocyte death, loss of intestinal barrier function, watery 
diarrhea and pseudomembranous colitis [2], [3]. The continued use of 
antibiotics during hospitalization and the collapse of the healthy gut 
microbiota are considered to be major risk factors for CDI outbreaks 
[4], [5]. CDI is a worldwide disease [6]. According to the Centers for 
Disease Control and Prevention (CDC), CDI has caused 14,000 deaths 
each year in the United States and costs more than $1 billion in medical 
expenses [7]. In Korea, the incidence of CDI increased from 1.9 per 
10,000 in 1998 to 8.82 in 2006–2007 [8]. For this reason, CDI-related 
prevention and treatment has been extensively studied around the world 
[5]. It has been confirmed that dysbiosis of intestinal microbiota plays a 
pivotal role in not only the severity of CDI symptoms but also the 
outbreak of CDI [9]. 
CDI begins by germinating in the gastrointestinal tract after the 
introduction of C. difficile spores through the oral cavity [10]. After 
spore germination, C. difficile causes symptoms by producing 
homologous toxin A and toxin B (toxin A&B) [11]. Toxin A&B binds 
to the epithelial cell surface and is internalized by endocytosis [12]. The 
glucosylation of the Rho family GTPases at the cell membrane by toxin 
A&B results in the inactivation of actin cytoskeleton intestinal 
epithelial cells [13]. In this case, the tight junction of the intestinal 
epithelial cells is loosened, and consequently, the gut permeability is 
increased along with the influx into the host of intestinal microbes, 
including C. difficile [14]. As a result, intestinal cell destruction leads to 
diarrhea and weight loss, and in severe cases, symptoms such as a 
megacolon or even death may occur [15].  
Secondary metabolites produced by commensal bacteria are 
known to play an important role in the germination and growth of C. 
difficile together with gut microbiota [16], [17]. Typically, secondary 
bile acid, deoxycholic acid (DCA), is known to inhibit C. difficile 
growth [18], [19]. Methylcholate is known to inhibit the binding of 
toxin A & B to the cell surface [20], and n-butyrate is known to regulate 
intestinal cell regeneration and immune response [21]. Therefore, to 
regulate CDI, it is necessary to understand the secondary metabolites 
produced by the commensal bacteria together with the gut microbiota 
[22]. 
 People with healthy gut microbiota are resistant to CDI [23]. 
However, specific components of the healthy gut microbiota that are 
resistant to CDI have pivotal functions that have not been completely 
investigated. Therefore, identifying specific strains that have CDI 
inhibitory effects in the healthy gut microbiota is necessary to solve the 
problem caused by CDI [24]. Understanding the link between 
commensal microbiota and C. difficile through these studies may 
contribute to preventing CDI-related complications such as the 
development of a megacolon [25]. This study aimed to identify the 
strains with CDI inhibitory effects and to find the factors associated 
with CDI inhibition by analyzing gut microbiota and gut metabolites. 
In previous studies, three strains (Lactobacillus plantarum 
SNUG 10271, Bacteroides ovatus SNUG 40239, and Clostridium 
scindens SNUG 40402) that inhibited the growth of C. difficile 
vegetative cells through an in vitro C. difficile inhibition assay were 
selected [41]. In this study, the CDI inhibitory effect of each strain was 
confirmed by the widely used CDI animal experimental model [26]. To 
find the clues necessary to reveal the mechanism of inhibition, five 
time-points were set throughout the experimental process to analyze gut 
microbiota and gut metabolome (Fig. 1).  
Taken together, we verified the in vivo CDI inhibitory effect of 
L. plantarum SNUG 10271. Also, it was confirmed that the abundance 
of specific bacterial taxa, such as Ruminococcaceae and Coprococcus, 
















II. Materials and Methods 
 
1. Culture condition of bacteria 
Bacteroides ovatus SNU 40239 (B. ovatus SNUG 40239), 
Clostridium scindens SNUG 40402 (C. scindens SNUG 40402) and 
Lactobacillus plantarum SNUG 10271 (L. plantarum SNUG 10271) 
isolated from Korean feces and Clostridium scindens KCTC 5591 (C. 
scindens KCTC 5591) (Type strain) were used as CDI inhibitory strains. 
B. ovatus SNU 40239 was cultured in brain heart infusion medium 
supplemented with 5% fetal bovine serum (BHIF). C. scindens SNUG 
40402 and C. scindens KCTC 5591 were cultured in Gifu Anaerobic 
Broth (GAM). L. plantarum SNUG 10271 was cultured in Man Rogosa 
Sharpe (MRS). Since all strains were anaerobic bacteria, they were 
inoculated in an anaerobic chamber (Coy, USA) containing a mixture 
of 5% H2 and CO2 in N2, as described previously with some 
modifications[27] and incubated at 37 ° C for 24 h. Single colonies 
were picked using sterile loops and inoculated into broth media and 
activated twice. Finally, 109 cells were used for animal experiments. 
 
2. Sporulation of C. difficile 
Clostridium difficile ATCC 43255 (C. difficile ATCC 43255) is 
adjusted to an OD value of 0.2 in broth and 100ul of C. difficile ATCC 
43255 is plated on SMC medium (90 g Bacto peptone, 5 g protease 
peptone, 1 g NH4SO4, 1.5 g Tris base, and 15 g agar per liter) [28]. 
After culturing at 37 ° C for seven days, all of the colony is scraped off 
and suspended in 1 ml of cold 1x PBS in a 1.7 ml tube. Store in this 
state at 4 ° C for 24 h. Spin down at 14000 rpm for 1 minute. Remove 
supernatant, wash with 1 ml of cold PBS, and spin down at 14000 rpm 
for 1 minute. After removing the supernatant, add 1 ml of 70% ethanol 
and store for 1 h. Spin down at 14000 rpm for 1 minute. Remove the 
supernatant and wash with 1 ml of sterile PBS. Store at -80°C until use. 
 
3. Murine C. difficile infection time-course experiment 
Mouse experiments were performed with C57BL/6 female 6-week 
old mice purchased from Orient Bio Inc. (Seongnam, Korea). All mice 
were maintained in a specific-pathogen-free facility at Seoul National 
University Hospital Biomedical Research Institute. Animal experiments 
were performed following Seoul National University Hospital 
Biomedical Research Institutional guidelines and approved by the 
institution’s Institutional Animal Care and Use Committee (IACUC). 
Five mice were randomly assigned to each cage in consideration of 
body weight and standard deviation, and the experiment started after a 
week of stabilization. 
Animal experiments were conducted in seven groups. Three group 
which are administered CDI inhibitor strain (Bacteroides ovatus SNU 
40239, Clostridium scindens SNUG 40402 and Lactobacillus 
plantarum SNUG 10271), Mix group with three CDI inhibitor strains at 
the same ratio, PBS positive control group, and Non-infected negative 
control group. Also, to measure the degree of the effect of the 
inhibitory strains, a total of seven groups including Clostridium 
scindens KCTC 5591, which has been proven to be effective, were 
tested [18]. 
Animal experiments followed the most widely used conventional 
methods [26]. 7 week old mice were fed water containing an antibiotic 
cocktail containing kanamycin (0.4 mg/mL), gentamicin (0.035 
mg/mL), colistin (850 U/mL), metronidazole (0.215 mg/mL), and 
vancomycin (0.045 mg/mL) for 3 days. After replacing the antibiotic 
cocktail with normal drinking water, four inhibitory strains (109 
CFU/mouse) were orally administered at 24 h intervals over the course 
of two days. 24 h after the final oral administration, 200 of 
clindamycin was intraperitoneally (IP) injected. Finally, Clostridium 
difficile ATCC 43255 spores (104) were administered orally 24 h after 
the administration of clindamycin IP. Weight loss and mortality post-
infection were measured at 24 h intervals over the course of eight days. 
To investigate microbiome and metabolome changes, we conducted 
mouse fecal sampling at five time-points. Fecal samples were collected 
at the following time points: at the pre-antibiotic treatment (day 0), 
post-antibiotic treatment has concluded (day 3), after treatment with 
candidate inhibitory strains (day 5), after Clindamycin IP injection (day 
6) and C. difficile spore infection (day 7). Fecal samples were collected 
in a sterile tube on a clean bench to prevent contamination and stored at 
-80°C until analysis. 
 
4. Measurement of C. difficile c.f.u. and toxin A&B 
Feces were weighed and dissolved in 1 ml PBS buffer in an 
anaerobic chamber. The diluted solution was then inoculated on C. 
difficile selective (agar chromID® Culture Media) (bioMérieux, USA) 
and incubated at 37°C for 48 hr. After counting, the number of cells 
was corrected by considering the weight of the stool. C. difficile toxin A 
and B were quantified using C. difficile TOX A/B II ELISA kit 
followed the product manuscript. (Techlab, USA). 
 
5. Fecal microbiota analysis 
The bacterial DNA contained in the fecal samples collected at the 
aforementioned time points were extracted using QIAamp DNA Stool 
Mini Kit according to the manufacturer's instruction (Qiagen, 
Germany). The V4 region of the 16S rRNA gene in the extracted fecal 
DNA was amplified with the Illumina-adapted universal primers 
515F/806R [29]. The amplified PCR products were purified using 
Qiagen PCR clean-up Kit (Qiagen, Germany). Then, the concentrations 
of the amplified PCR products were measured using the KAPA Library 
Quantification Kit (KAPA biosystems, USA) and ABI 7300 (Applied 
Biosystems, USA). Finally, the quantified PCR products were pooled 
after calibrating the concentration constant and sequenced using the 
Miseq platform (Illumina, USA). 
Sequence data was analyzed using a Quantitative Insights into 
Microbial Ecology (QIIME) platform (ver. 1.8.0) and clustered into 97% 
identity using a closed method operational taxonomic unit (OTU) 
picking method [30]. After alignment, OTU were classified using the 
Ribosomal Database Project (RDP) classifier based on the Greengene 
database. It was analyzed to the species level based on the OTU table 
and relative abundance calculated. 
Beta diversity between each group and time point was analyzed 
using Unifrac distance. Linear discriminant analysis (LDA) effect size 
(LEfSe) analysis was used to find bacterial biomarkers among different 
groups [31]. Finally, Kyoto Encyclopedia of Genes and Genomes 
(KEGG) pathway database-based Phylogenetic Investigation of 
Communities by Reconstruction of Unobserved States (PICRUSt) 
analysis was conducted to investigate the differences in bacterial 
function among the microbiomes of the different mouse groups [32]. 
 
6. Quantification of DCA and metabolome analysis of fecal 
samples 
Feces were weighed, and 80% methanol was added at 1: 1 ratio to 
extract bile acids and metabolites in feces. After sonication for 3 min 
and centrifugation at 13,000 rpm for 1 min, the supernatant was filtered 
with 0.22 μm filter. The filtered fecal metabolite solution was then 
evaporated in Speedback (Eppendorf, Germany), after which 
metabolites contained within the fecal sample, including bile acid, were 
obtained in a powder and stored at -80°C until analysis [18]. 
Bile acids (TCA, CA, CDCA, LCA, DCA) separation was 
performed using an Acquity UPLC BEH C18 column (100 mm × 2.1 
mm, 1.7 m) and Acquity UPLCTM system (Waters). The analysis 
conditions for chromatography were as follows: mobile phase A, water 
with 0.1% formic acid; mobile phase B, acetonitrile with 0.1% formic 
acid; injection volume, 2 μl. The time gradient of mobile phase B was 
from 5% to 90% in 15 min, and the flow rate was 0.4 ml/min. 
Qualitative bile acids analysis was conducted using Waters Synapt G2-
Si Q-TOF mass spectrometer (Waters) equipped with an electrospray 
(ESI) probe and negative ionization mode with the tofMRM mode. For 
the Synapt G2-Si Q-TOF, the following mass spectrometer parameters 
were applied: capillary, 25kV; source temperature, 100°C; sampling 
cone, 40; source offset, 80; desolvation temperature, 250°C; cone gas 
flow, 50 L/h; desolvation gas flow, 600 L/h; nebuliser gas flow, 6.5 Bar. 
The measured bile acid was quantified using QuanLynx of MassLynx 
program [33]. 
Supernatant metabolite measurement was performed in positive 
ionization mode and MSe scan mode using the same column and UPLC 
conditions. The mass range was set from 50 to 1200 Da and the scan 
time was set to 0.2 sec. The following mass spectrometer parameters 
were used: capillary, 2 kV; source temperature, 120°C; sampling cone, 
40; source offset, 80; desolvation temperature, 400°C; cone gas flow, 
50 L/h; desolvation gas flow, 600 L/h; nebuliser gas flow, 6.5 bar. All 
systems were controlled by Mass-LynxTM software 4.1 (Waters) [33]. 
Intergroup metabolism analysis was carried out by transferring 
MassLynxTM software to the Progenesis QI software (Waters). A 
retention time window of 0.20 min and mass tolerance of 1.0 ppm were 
set to align the compounds. Then, ANOVA p-value and max fold 
change were applied to filter compounds and then exported to EZinfo 
software (version 3.0.3.0) for principal component analysis (PCA) [34]. 
 
7. Statistical analysis 
All statistical analysis was performed using Prism 7 (GraphPad 
Software, USA). Statistical significance was measured using Mann-
Whitney test to analyze differences between two groups with similar 
variances and the Kruskal–Wallis test with Dunn correction for 
multiple comparisons was used when three or more groups were 
measured with similar variances. In all graphs, data were presented as 
mean + standard error of mean (SEM). Statistical significance was 
given as * P-value < 0.05, ** P-value < 0.01, *** P-value < 0.001. 
III. Results  
 
1. L. plantarum SNUG 10271 inhibit clinical symptoms of CDI 
After inducing CDI, changes in symptoms between groups 
were observed to evaluate the effect of CDI inhibitory strains. The 
priority factors in determining the severity of CDI symptoms, weight 
loss, and mortality, were monitored for eight days after CDI. As a result, 
a significant change in body weight was not observed for 24 h after the 
infection, but the weight of all groups decreased rapidly from 24 h to 
72 h (Fig. 2a). However, among the five groups (L. plantarum SNUG 
10271, B. ovatus SNUG 40239, C. scindens SNUG 40402, C. scindens 
KCTC 5591, Mix) treated with the distinct inhibitory strain prior to 
infection, only the L. plantarum SNUG 10271 group lost less than 7% 
on average of their weight (Fig. 2b, c). Compared to other groups, this 
inhibition of weight loss was significant at 48 and 72 h after CDI (Fig. 
2b, c). 
 The mortality rate was also observed consistent with weight 
loss. The first deaths occurred in the Mix group at 48 h after infection, 
when rapid weight loss occurred (Fig. 3a). After that, death occurred in 
all groups except the L. plantarum SNUG 10271 group and the Non-
infection group for six days after the infection (Fig. 2a). To summarize, 
only one mouse died within the C. scindens SNUG 40402 group, the 
Mix group and the C. scindens KCTC 5591 group, and four mice died 
in the B. ovatus SNU 40239 group (Fig. 3a). Three mice died in the 
PBS group (Fig. 3a). 
The feces gathered at 24 and 48 h following infection was used 
to measure the abundance of C. difficile c.f.u. and toxin A&B titer 
responsible for the severity of CDI symptoms. Unlike weight loss and 
mortality, there was no significant decrease in C. difficile c.f.u. at 24 
and 48 h after CDI (Fig. 3c, d). Also, there was no significant statistical 
difference in toxin A&B titer between groups (Fig. 3b). However, a 
tendency for lower toxin A&B titer was observed in the L. plantarum 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































2. Comparison of gut microbial diversity  
Gut microbial diversity analysis was performed to find the 
difference of gut microbiota structure associated with CDI inhibition 
effect of the administered bacteria. Alpha diversity was analyzed using 
the Chao 1 index to measure species richness in the group. Also, non-
metric multidimensional scaling (NMDS) for beta diversity was 
conducted to determine whether there is a difference in species 
diversity between groups. As a result of the alpha diversity 
measurements, species richness was lower in all groups after antibiotic 
administration, as expected (Fig. 4a). This species richness did not 
recover to pre-antibiotic (Day 0) levels at the time point when the CDI 
inhibitory effect was observed in the L. plantarum SNUG 40329 group 
(Day7). (Fig. 4a). While, the B. ovatus SNUG 40239 group, which 
showed the most severe symptoms after CDI, showed a more 
significant decrease in species richness after clindamycin IP than the 
Non-infection group did (Fig. 4a). Also, it was confirmed that the 
species richness in all groups after antibiotic treatment did not recover 
to the species richness present before antibiotic treatment (Fig. 4a). 
Beta diversity analysis was conducted to determine whether 
species diversity between groups was related to CDI inhibition when 
there was no inter-group difference in species richness. However, the 
clustering of the L. plantarum SNUG 10271 group distinct from other 
groups was not observed (Fig. 4b). As a result, the Mix group and the B. 
ovatus SNUG 40239 group were clustered into one group, and the 
remaining groups were clustered together (Fig. 4b). That is, there was 





















































































































































































































































































3. The characterization of specific bacterial taxa in the group with 
the CDI inhibitory effect 
Although there was no difference in alpha and beta diversity 
among the groups, LEfSe analysis was performed to find bacterial taxa 
that differed significantly between groups. As a result, at 24 h after CDI, 
a significantly higher abundance of bacterial taxa was observed in each 
group. An analysis of all groups showed that there was a significant 
amount of Ruminococcaceae in the L. plantarum SNUG 10271 group 
(Fig. 5a). Also, Ruminococcaceae abundance was significantly higher 
in the L. plantarum SNUG 10271 group than the PBS group used as 
positive control (1:1) (Fig. 5b). Also, Coprococcus and Clostridium 
were also observed as significantly more abundant bacterial taxa in the 
L. plantarum SNUG 10271 group (Fig. 5b). By contrast, the B. ovatus 
SNUG 40239 group, which had the worst symptoms of CDI, had a 
significantly higher abundance of Bacteroidetes, Bacteroidia, 
Bacteroidales, Bacteroidaceae, and Bacteroides (Fig. 5b). 
Next, all of the fecal microbiota sequencing data acquired from 
the CDI without group division was used to analyze the Spearman 
correlation between C. difficile and other bacterial taxa at the species 
level. As a result, Clostridium, Ruminococcaceae, Coprococcus, and 
Akkermansia muciniphilia were identified as bacterial taxa that were 
negatively correlated with C. difficile (Table. 1). On the other hand, 
Clostridium perfringens, Escherichia, and Enterococcus were 
positively correlated with C. difficile (Table. 1). 
As a result, it was observed that Ruminococcaceae and 
Coprococcus were biomarker taxa of the L. plantarum SNUG 40239 




























































































































































































































































































































































































































































































































































































































































































































































































































































4. CDI-related functional profile of gut microbiota 
Previous microbiota analysis based on OTU showed no difference 
in beta diversity between groups. However, there were differences 
between the groups regarding the symptoms that followed infection. 
Also, certain bacterial taxa such as Ruminococcaceae and Coprococcus 
were present in different abundance. These results indicate that the 
intergroup microbiota was not the same, and we recognized the 
necessity of further analysis on microbiota at the metabolic functional 
level. The metabolic functional potential of each group was analyzed 
by PICRUSt based on the KEGG pathway and the results were used to 
observe beta diversity between the groups. Interestingly, each group 
was clustered (Fig. 6a). And the L. plantarum SNUG 10271 group with 
the best CDI inhibitory effect was located closest to the Non-infection 
group as a control (Fig. 6a). In addition, the secondary bile acid 
biosynthesis gene family was showed more tendency to be more in the 
























































































































































































































































5. The characterization of specific bacterial metabolites in the 
group with a CDI inhibitory effect 
Due to the difference in beta diversity based on the PICRUSt 
analysis results, a metabolite analysis was conducted to find the 
metabolites associated with CDI inhibition. The  PCA analysis was 
performed based on the statistically significant 11088 metabolites. As a 
result, a clustering phenomenon for individuals in each group was 
observed at Day7 (Fig. 7a). The L. plantarum SNUG 10271 with the 
best CDI inhibitory effect and the Non-infection groups were clustered 
to the upper left section (Fig. 7a). The PBS group and the B. ovatus 
SNUG 40239 group, which had the most severe symptoms of CDI, 
tended to cluster together (Fig. 7a). Also, the C. scindens SNUG 40402 
groups and the C. scidnens KCTC 5591 group, which were more 
implicated in controls and B. ovatus SNUG 40239 on mortality, were 
observed to be clustered in the lower right section (Fig. 7a). The Mix 
group was distributed in both the B. ovatus SNUG 40239 group and the 
L. plantarum SNUG 10271 group (Fig. 7a). 
Through PCA analysis, we were able to deduce the difference 
in metabolites between groups and found that the metabolites of the 
groups could be different. To find a biomarker metabolite in the L. 
plantarum SNUG 10271 group, the PCA plot was converted into a 
loading plot and analyzed. As a result, we found that two metabolites 
that were present significantly high abundance only in the L. plantarum 
SNUG 10271 group and the Non-infection group; identification 
through MassLynx confirmed that the dimer and trimer of DCA formed 
during the ionization of two metabolites using ESI (Fig. 7b). 
To verify whether DCA exists at a significantly high 
concentration in the L. plantarum SNUG 10271 group, we performed 
quantitative analysis in tofMRM mode using standard bile acids, TCA, 
CA, CDCA, LCA, and DCA. As a result, DCA was measured at 
significantly higher concentrations in the L. plantarum SNUG 10271 
group compared with the PBS group, the C. scindens SNUG 40402 and 
the B. ovatus SNUG 40239 group after 24 h of CDI (Day8). In 
summary, DCA was determined to be a biomarker in the L. plantarum 
SNUG 10271 group, suggesting the CDI inhibitory effect is correlated 























































































































































































































































































































































































































































6. The correlation of gut microbiota with bile acids. 
We analyzed the correlation between DCA and gut microbiota 
for understanding the CDI inhibitory effects observed in the L. 
plantarum SNUG 10271 group. The Spearman correlation between the 
microbiota of the L. plantarum SNUG 10271 group at all time points 
and DCA concentration was analyzed. As a result, it was observed that 
Ruminococcaceae had the highest positive correlation with DCA (Fig. 
9). Coprococcus and Lachnospiraceae were also observed to have a 
positive correlation (Fig. 9). Among the bacterial taxa with a positive 
correlation with DCA, Clostridium orbiscindens was specified to the 
species level (Fig. 9). On the other hand, Akkermansia muciniphilia and 
Parabacteroides were observed to be negatively correlated with DCA 
(Fig. 9). 
Furthermore, the Spearman correlation between microbiota and 
other bile acids, such as TCA, CA, CDCA, DCA and LCA, 
concentrations associated with C. difficile spore germination and 
growth were analyzed without group discrimination at the post-
infection time point (Day7). Consequently, it was observed that 
Coprococcus and Ruminococcaceae had a negative correlation with 
TCA, but a positive correlation with the secondary bile acids, DCA and 
LCA (Fig. 10). On the other hand, Lactobacillus and C. difficile showed 
strong negative correlation with DCA and LCA (Fig. 10). In the case of 
Prevotela and Bacteroidales, it was observed that there was a high 











































































































































































































































































































































































































The most important risk factor causing CDI is the use of 
various antibiotics [35]. Antibiotic use disrupts the healthy gut 
microbiota structure that prevents CDI in normal conditions [5]. For 
that reason, the goal of this study was to identify the strains with CDI 
inhibitory effects and to find the bacterial taxa and metabolites 
associated with inhibition by analyzing gut microbiota and gut 
metabolites. In this study, essential information for CDI prevention was 
found. Through experimentation, we have discovered the CDI 
inhibitory effect of L. plantarum SNUG 10271. In the process, DCA, 
which is known as a metabolite inhibiting C. difficile growth, was 
measured at a statistically significantly high concentration in the L. 
plantarum SNUG 10271 group. Also, we found the presence of the 
bacterial taxa Ruminococcucea and Coprococcus, which were not 
mentioned previously in relation to CDI. 
The group administered L. plantarum SNUG 10271 showed a 
CDI inhibitory effect in this study. This inhibitory effect was assessed 
by measuring body weight change, mortality, C. difficile c.f.u., and 
toxin A&B titer. When compared to other groups, the L. plantarum 
SNUG 10271 group had a statistically significant inhibitory effect on 
body weight loss and mortality. Body weight loss is considered to be 
significant, meaning that the average weight loss was reduced to within 
7%. According to the prior studies, the weight loss of the PBS group as 
a positive control is around 10% [18], [36]. By contrast, this 
experiment showed that the body weight of the PBS group decreased 
by 19.8% at 72 h of infection. Based on this aspect, it can be seen that 
the inhibitory effect of L. plantarum SNUG 10271 on CDI is quite 
effective. 
In addition, interesting results were observed in weight changes. 
In the B. ovatus SNUG 40239 group, the mean value of weight loss was 
greater than that of the PBS group as a control, and the mortality rate 
was one more death than the PBS group. Whereas, both the weight loss 
and mortality of the L. plantarum SNUG 10271 group indicated that L. 
plantarum SNUG 10271 was more effective at inhibiting CDI than the 
PBS group. These results suggest that the use of a single bacterial strain 
could control the severity of CDI symptoms.  
While the L. plantarum SNUG 10271 group showed a 
significant effect on weight loss and mortality, there was no statistically 
significant difference detected in the C. difficile c.f.u. and the toxin 
A&B titer. Two reasons for this may be considered. First, there may be 
cases where the process of toxin action on cells is inhibited. Toxin 
should be bound to the intestinal epithelial cell surface to induce 
symptoms [37]. However, such binding may be inhibited by secondary 
metabolites produced by gut microbiota. The secondary metabolites 
from L. plantarum SNUG 10271 could inhibit the cell binding of the 
toxins that lead to the symptoms. Therefore, this possibility cannot be 
totally dispensed with. Second, there may be errors resulting from the 
stool weighing process. CDI mice begin to show severe diarrhea 
symptoms beginning at 36 h of infection. These diarrhea symptoms 
lasted up to 96 h after infection. At the time point where the symptoms 
are most severe, the GI tract of the infected mouse was observed to be 
empty. The individuals whose fecal samples were measured for C. 
difficile c.f.u. and toxin A&B also had severe diarrhea symptoms. Thus, 
a large proportion of the collected feces contained transparent liquids 
such as mucus. This was reflected in the weighing of the feces, and an 
accurate weighing of the part containing the bacteria was not carried 
out, which may have affected the C. difficile c.f.u. and toxin A&B titer 
results. In fact, in some papers, the C. difficile c.f.u. and toxin A&B 
titer is measured using cecum content at 24 and 48 h, when symptoms 
become severe [18], [38], [39]. In this case, it is difficult to observe the 
symptoms after CDI. In our study, when comparing the pellets of feces 
that had met the minimum weight and the pellets weighing more than 
the minimum weight, it was observed that the mass of the pellet was 
larger in the second case than for the first. Given these considerations, 
the failure of the C. difficile c.f.u. and toxin A&B titer to be consistent 
with weight change and mortality may be associated with the weighing 
error present in the feces weight measurement. 
The interesting result of this experiment was observed in the 
beta diversity. When beta diversity was measured with OTU as the 
input data, clustering between groups was not observed. However, 
when beta diversity based on the functional profile of gut microbiota 
was measured, clustering between the groups was observed. This 
phenomenon can be interpreted based on two cases. The first is that the 
diversity of gut microbiota may be similar but different in each 
bacterial taxa level. In other words, although the number of bacterial 
taxa constituting the groups is similar, there could be a difference in the 
kind of each bacterial taxa constituting the groups. The differences 
between the kind of the bacterial taxa differ from the functional aspect. 
Actually, the metabolic function of the microbiota composed of 
different bacterial taxa may be similar [40]. The second reason is found 
in the process of sequence matching the functional profile of gut 
microbiota via OTU. OTU identifies specific taxa through a process 
using QIIME. At this time, even if two OTUs are identified as 
belonging to the same taxa, the sequence of two OTUs may not be 
completely identical. The sequence differences between OTUs 
identified as the same genus or species can be interpreted as different 
functions in the process of predicting functions of microbial community 
through PICRUSt. Therefore, it can be considered that the small 
difference in sequences that exists in OTU is reflected in the functional 
prediction, and as a result, it is considered that the phenomenon of each 
clustered group was observed. 
The functions of microbial community produced with 
PICRUSt indicates that there was a difference in metabolic functions 
between groups. The same phenomenon was observed when PCA 
analysis was performed by measuring actual metabolites. There was, 
however, a difference between groups that were clustered together. This 
phenomenon is considered to be the gap between the predicted score 
and actual metabolic activity. Metabolites, which were seen as markers 
in the L. plantarum SNUG 10271 group, were identified by DCA, and a 
large amount of DCA concentration was measured in the L. plantarum 
SNUG 10271 group.  
However, there are some things which need to be considered. 
First, L. plantarum SNUG 10271 does not have complete gene sets that 
relate the secondary bile acid DCA. Nevertheless, in the group given L. 
plantarum SNUG 10271, a significantly higher concentration of DCA 
was measured after CDI. Namely, the increase in DCA concentration is 
the output of the changes caused by L. plantarum SNUG 10271, and in 
this experiment, this change is considered to have increased 
Ruminococcaceae and Coprococcus abundancy. The next point to 
consider is that the C. difficile c.f.u. did not decrease even though the 
concentration of DCA increased. However, as mentioned previously in 
this section, this may reflect a measurement error in the process of 
weighing the feces. Therefore, an additional experiment cohort is 
needed to confirm the C. difficile c.f.u. using cecum and to verify it 
more clearly. 
We should also consider the presence of Ruminococcaceae and 
Coprococcus, which showed a positive correlation with DCA 
concentration and a negative correlation with C. difficile abundance. 
Both taxa have not been reported in relation to CDI in previous studies. 
However, since the taxa level currently identified is a family level and 
genus level, it is considered important to classify these taxa to the 
species level. The reason that finding precise species in respect to 
Ruminococcaceae and Coprococcus is significant is that it showed that 
the change of abundance of some specific bacterial species may 
potentially affect CDI symptom inhibition even though there is no 
difference in alpha diversity and beta diversity.  
Taken together, in this study, Ruminococcaceae and 
Coprococcus increased with the administration of the L. plantarum 
SNUG 10271 group, and an increase in DCA concentration was 
observed in the same group. As a result, mice in the L. plantarum 
SNUG 10271 group with this phenomenon showed CDI inhibition in 
regards to weight loss and mortality. Because this experiment requires a 
larger number of individuals to discuss statistical significance more 
reliably, additional iterative experiments are needed to confirm the 
effect of L. plantarum SNUG 10271 on CDI inhibition. Only the results 
of inhibition phenomenon, such as the effects on Ruminococcaceae and 
Coprococcus and DCA, have been shown. The mechanism of inhibition 
caused by L. plantarum SNUG 10271 is not completely understood. 






   Lactobacillus plantarum
 Clostridium difficile    
 
 

